Literature DB >> 1000478

Endodermal sinus tumor of the pineal region: case report.

G Prioleau, C B Wilson.   

Abstract

This is a case report of an endodermal sinus tumor occurring in the pineal region of a 12-year-old Caucasian boy. Germ cell tumors of this type demonstrate a selective overgrowth of yolk sac endoderm associated with extraembryonic mesoblast and arise perferentially in the gonads of young children. This is the ninth known report of this tumor in the world literature. Its occurrence in the posterior third ventricle again confirms that pineal region germ cell tumors are histologically analogous to germ cell tumors originating in the gonads. A disturbance in the region of the primitive streak is thought to account for the exclusive midline location of this tumor in extragonadal sites. This patient was treated with a combination of vincristine, actinomycin D, and cyclophosphamide, and concomitant cobalt irradiation. For endodermal sinus tumors in the pineal region, this combination appears more effective than previously reported treatment by irradiation alone.

Entities:  

Mesh:

Year:  1976        PMID: 1000478     DOI: 10.1002/1097-0142(197612)38:6<2489::aid-cncr2820380638>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Tumours in the pineal and supra-sellar region. A review of clinical manifestations and managements.

Authors:  K Watne
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

2.  alpha-feto-protein (AFP) and human chorionic gonadotropin (HCG) as biochemical markers of intracranial germ-cell tumours.

Authors:  J Haase; B Børgaard-Pedersen
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

3.  An attempt to treat pediatric intracranial alphaFP and betaHCG secreting germ cell tumors with chemotherapy alone. SFOP experience with 18 cases. Société Française d'Oncologie Pédiatrique.

Authors:  M C Baranzelli; C Patte; E Bouffet; M Portas; F Mechinaud-Lacroix; E Sariban; H Roche; C Kalifa
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.